参考文献/References:
[1]Melmed S.Pituitarytumor endocrinopathies.N Engl J Med,2020,382(10):937-950.
[2]Cossu G,Jouanneau E,Cavallo LM,et al.Surgical management of giant pituitary neuroendocrine tumors:metaanalysis and consensus statement on behalf of the EANS skull base section.Brain Spine,2022,2:100878.
[3]Iglesias P,Rodriguez Berrocal V,Diez JJ.Giant pituitary adenoma:histological types,clinical features and therapeutic approaches.Endocrine,2018,61(3):407-421.
[4]中国垂体腺瘤协作组.中国垂体腺瘤外科治疗专家共识.中华医学杂志,2015,95(5):324-329.
[5]Micko AS,Whrer A,Wolfsberger S,et al.Invasion of the cavernous sinus space in pituitary adenomas:endoscopic verification and its correlation with an MRIbased classification.J Neurosurg,2015,122(4):803-811.
[6]Solari D，Cavallo LM，Graziadio C，et al.Giant nonfunctioning pituitary adenomas:treatment considerations.Brain Sci,2022,12(9):1256.
[7]刘希光，李爱民，李宁，等.经颅切除巨大侵袭型垂体腺瘤手术入路的选择与显微手术策略.脑与神经疾病杂志,2013,21(4):293-297.
[8]Jin BZ,Yuan GY,Yue SZ,et al.The use of transcallosalinterforniceal approach for microsurgical removal of the third ventricle tumors.J Neurosurg Sci,2015,59(1):19-24.
[9]Tatsi C,Stratakis CA.Aggressive pituitary tumors in the young and elderly.Rev Endocr Metab Disord,2020,21(2):213-223.
[10]向毅，孙梅，李冰，等.翼点入路与额外侧锁孔入路切除巨大型垂体腺瘤(附60例报告).中国神经精神疾病杂志,2011,37(2):106-108.
[11]李坪.经翼点入路显微手术切除巨大垂体腺瘤的疗效分析.航空航天医学杂志,2020,31(10):1217-1218.
[12]Hernesniemi J,Ishii K,Niemel M,et al.Lateral supraorbital approach as an alternative to the classical pterional approach.Acta Neurochir Suppl,2005,94:17-21.
[13]Park HH,Sung KS,Moon JH,et al.Lateral supraorbital versus pterional approach for parachiasmal meningiomas:surgical indications and esthetic benefits.Neurosurg Rev,2020,43(1):313-322.
[14]余信远,刘仁忠,简志宏,等.额颞硬膜外-下入路手术治疗海绵窦侵袭性垂体腺瘤.中国临床神经外科杂志,2019,24(5):304-305.
[15]Luzzi S,Giotta Lucifero A,Rabski J,et al.The party wall:redefining the indications of transcranial approaches for giant pituitary adenomas in endoscopic era.Cancers,2023,15(8):2235.
[16]高阳，郝斌，李德亨，等.垂体瘤外科诊疗进展.中华神经外科疾病研究杂志,2017,16(5):478-480.
[17]Mamelak AN.Pro:endoscopic endonasal transsphenoidal pituitary surgery is superior to microscopebased transsphenoidal surgery.Endocrine,2014,47(2):409-414.
[18]吴新宇,侯小川,鲍跃,等.Knosp分级和海绵窦分区在侵袭性垂体瘤经鼻内镜手术中的临床意义.中国现代神经疾病杂志,2019,19(3):170-176.
[19]冯乐霄,李晶.CATA结合蛋白-6、碱性成纤维细胞生长因子基因在垂体瘤组织中的表达及与临床病理特征关系.陕西医学杂志,2023,52(2):217-221.
[20]刘开东,杭春华,丛子翔,等.内镜下经鼻入路显微切除侵袭海绵窦垂体瘤.临床神经外科杂志,2020,17(2):121-124,129.
[21]FernandezMiranda JC，Tormenti M，Latorre F，et al.Endoscopic endonasal middle clinoidectomy:anatomic,radiological,and technical note.Neurosurgery,2012,71(2 Suppl Operative):ons233-239.
[22]PinheiroNeto CD，FernandezMiranda JC，Prevedello DM，et al.Transposition of the pterygopalatine fossa during endoscopic endonasal transpterygoid approaches.J Neurol Surg B Skull Base,2013,74(5):266-270.
[23]贾亮，周航，张晓炜，等.内镜下扩大经鼻入路手术切除鞍上侵袭性垂体腺瘤.中国现代神经疾病杂志,2023,23(7):586-590.
[24]Marigil Sanchez M,Karekezi C,Almeida JP,et al.Management of giant pituitary adenomas:role and outcome of the endoscopic endonasal surgical approach.Neurosurg Clin N Am,2019,30(4):433-444.
[25]Joshi KC,Kolb B,Khalili BF,et al.Surgical strategies in the treatment of giant pituitary adenomas.Oper Neurosurg (Hagerstown),2023 Sep 1.Epub ahead of print.
[26]Kuga D,Toda M,Ozawa H,et al. Endoscopic endonasal approach combined with a simultaneous transcranial approach for giant pituitary tumors.World Neurosurg,2019,121:173-179.
[27]王云锋,闫惠颖,杭春华,等.经鼻蝶入路神经内镜手术联合眶上外侧入路显微手术治疗大型垂体腺瘤.中国临床神经外科杂志,2022,27(12):961-963.
[28]望家兴，黄银兴，王守森.巨大型垂体腺瘤评估与经蝶入路手术技术.中国微侵袭神经外科杂志,2017,22(5):234-236.
[29]Yildirim A，Sahinoglu M，Ekici I，et al.Nonfunctioning pituitary adenomas are really clinically nonfunctioning?Clinical and endocrinological symptoms and outcomes with endoscopic endonasal treatment.World Neurosurg,2016,85:185-192.
[30]Byun YH,Kang H,Kim YH.Advances in pituitary surgery.Endocrinol Metab (Seoul),2022,37(4):608-616.
[31]Cappabianca P，Cavallo L，Solari D，et al.Size does not matter.The intrigue of giant adenomas:a true surgical challenge.Acta Neurochir (Wien),2014,156(12):2217-2220.
[32]王任直，任祖渊，苏长保，等.巨大垂体腺瘤的治疗策略.中华显微外科杂志,2005,28(2):106-108,193.
[33]Shimon I.Giant prolactinomas.Neuroendocrinology,2019,109(1):51-56.
[34]Colao A，Savastano S.Medical treatment of prolactinomas.Nat Rev Endocrinol,2011,7(5):267-278.
[35]Tritos NA,Miller KK.Diagnosis and management of pituitary adenomas:a review.JAMA,2023,329(16):1386-1398.
[36]Zhao K,Liu X,Liu D,et al.Fractionated gamma knife surgery for giant pituitary adenomas.Clin Neurol Neurosurg,2016,150:139-142.
[37]Gaillard S,Adeniran S,Villa C,et al.Outcome of giant pituitary tumors requiring surgery.Front Endocrinol (Lausanne),2022,13:975560.